In this image, my 19-month-old Makåhna is admiring the såkman model that is part of the “I Hinanao-ta” Exhibit at the Guam ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high costs—often exceeding $1,000 per month—put them out of reach for many Americans whose ...